文献速递神经头颈MR

CLIPS分级系统用于预测垂体神经内分泌肿瘤海绵窦分区侵犯

Development of the CLIPS Grading System to Predict Invasion of Cavernous Sinus Compartments in Pituitary Neuroendocrine Tumors (Pituitary Adenoma).
PubMed 文献 · AJNR Am J Neuroradiol · 2026-07-09

针对垂体神经内分泌肿瘤海绵窦侵犯评估,本研究开发CLIPS分级系统,按外侧、下、后、上及床突间隙五个海绵窦分区逐一评分。共纳入255例经蝶内镜手术患者(510侧海绵窦),以术中评估或术后MRI为参考标准。结果显示CLIPS总体敏感度90.8%、特异度98.4%、准确度97.6%,优于Knosp分级,观察者间一致性亦更高。

要点

  • CLIPS分级按海绵窦各分区以颈内动脉中线为界评分,0为未过线,1为过线。
  • CLIPS预测海绵窦侵犯的总体准确度达97.6%,明显优于传统Knosp分级。
  • 既往手术可增加CLIPS 0级上、后分区及Knosp 2级的真实侵犯率,阅片需警惕。

核心结论

  • CLIPS分级系统是评估垂体神经内分泌肿瘤海绵窦分区侵犯的可靠且准确的工具,可更好地辅助垂体外科医生。
  • CLIPS分级在海绵窦各分区的预测效能相当,总体准确度为97.6%(95%CI 96.9-98.2%)。

研究设计与样本

  • 回顾性队列研究,纳入255例接受经蝶内镜鼻内入路手术的患者,共510侧海绵窦。
  • 其中经海绵窦扩展手术组139侧海绵窦,常规经蝶手术组371侧海绵窦。
  • 海绵窦分区侵犯以经海绵窦扩展组的术中评估及常规经蝶组的术后MRI作为参考标准验证。
  • 将CLIPS分级与Knosp分级进行对比,并按卒中、功能状态及既往手术分层分析。
  • 在部分病例中计算观察者间一致性。

关键影像表现/征象

  • CLIPS分级针对海绵窦外侧、下、后、上分区及床突间隙分别评估肿瘤侧方扩展程度。
  • 以一条沿解剖平面平分颈内动脉的线为界,肿瘤位于该线内侧为0级,外侧为1级。

诊断标准与关键数值

  • 海绵窦分区侵犯存在于19.4%的海绵窦侧及37%的患者中。
  • CLIPS分级预测侵犯的总体敏感度为90.8%(95%CI 86.6-94%)。
  • CLIPS分级预测侵犯的总体特异度为98.4%(95%CI 97.8-98.9%)。
  • CLIPS分级预测侵犯的阳性预测值为86.5%(95%CI 82.3-89.8%),阴性预测值为99%(95%CI 98.5-99.3%)。
  • CLIPS分级预测侵犯的总体准确度为97.6%(95%CI 96.9-98.2%),各分区结果相当。

临床应用与阅片要点

  • 阅片时应按CLIPS分区逐一评估肿瘤与颈内动脉中线的关系,避免笼统判断海绵窦是否受侵。
  • 对CLIPS 0级上、后分区及Knosp 2级病例,有既往手术史时需提高侵犯警惕性。
  • CLIPS分级较Knosp分级更适合作为术前规划经海绵窦扩展手术的影像学依据。

局限性

  • 既往手术可影响特定CLIPS 0级分区及Knosp 2级病例的侵犯率判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Assessment of cavernous sinus (CS) invasion is of paramount importance in planning the surgical treatment of pituitary neuroendocrine tumors (PitNET). The most widely used classification - the Knosp grading system - has limitations that lead to highly variable prediction of true CS invasion, and low interobserver agreement. We set out to develop a classification system to address these limitations.

MATERIALS AND METHODS: The CLIPS classification was developed by evaluating each CS compartment (Lateral, Inferior, Posterior, Superior, and Clinoidal space). For each compartment, a single line bisecting the carotid artery, following anatomical planes, was used to grade the lateral extension of the PitNET. Tumors medial to these lines were graded as 0, and those lateral to it were graded as 1 for a given compartment or space. This classification was used to evaluate 255 patients (510 CS) who underwent transsphenoidal endoscopic endonasal approach (EEA) surgery, either with transcavernous extension (TC-EEA group = 139 CS) or without it (EEA group = 371 CS). Compartmental invasion was validated by intraoperative assessment in the TC-EEA group, and by postoperative MRI in the EEA group. Results were compared with the Knosp classification, stratified by the presence of apoplexy, functional status, and previous surgery. Inter-observer agreement (IOA) was calculated in a sample of these cases.

RESULTS: Cavernous sinus compartment invasion was present in 19.4% of CS and 37% of patients. CLIPS classification yielded an overall sensitivity of 90.8% (95% CI 86.6-94%), specificity of 98.4% (95% CI 97.8-98.9%), PPV of 86.5% (95% CI 82.3-89.8%), NPV of 99% (95% CI 98.5-99.3%), and accuracy of 97.6% (95% CI 96.9-98.2%) for predicting invasion, with comparable results in all compartments. Previous surgery increased the rate of invasion for CLIPS grade 0 in the superior and posterior compartments, as well as in Knosp grade 2 cases. IOA was almost perfect for superior and inferior compartments, and substantial for lateral, posterior, and clinoidal space. Knosp classification achieved only moderate agreement.

CONCLUSIONS: The CLIPS classification provides a reliable and accurate tool to evaluate CS compartment invasion by PitNET, incorporating the assessment of each CS compartment to better assist pituitary surgeons.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Constanzo, Decker, Rychen, et al. Development of the CLIPS Grading System to Predict Invasion of Cavernous Sinus Compartments in Pituitary Neuroendocrine Tumors (Pituitary Adenoma). AJNR Am J Neuroradiol. 2026. PMID: 42425759. doi:10.3174/ajnr.A9516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。